Pharma and Biotech
By Josh White
Date: Tuesday 30 Jul 2019
(Sharecast News) - Bangladesh-based generic pharmaceuticals manufacturer Beximco Pharmaceuticals has started the export of blood pressure drug 'Nadolol' to the United States market, it announced on Tuesday.
By Josh White
Date: Wednesday 24 Apr 2019
(Sharecast News) - Beximco Pharmaceuticals announced on Wednesday that it has received US Food and Drug Administration (FDA) approval for its cyproheptadine hydrochloride tablet 4mg anti-allergy drug, which is a generic equivalent to 'Periactin' 4mg tablets from Merck and Company.
By Josh White
Date: Wednesday 20 Feb 2019
(Sharecast News) - Generic drugs manufacturer Beximco Pharmaceuticals announced the signing of a definitive agreement with Sandoz - a division of Novartis - to acquire a portfolio of eight 'Abbreviated New Drug Applications' (ANDAs) in the US on Wednesday, for an undisclosed amount in cash.
Monday broker round-up | 30-Jul-2018 | ShareCast |
Monday broker round-up | 23-Jul-2018 | ShareCast |
Monday broker round-up | 23-Apr-2018 | ShareCast |
Tuesday broker round-up | 03-Apr-2018 | ShareCast |
Monday broker round-up | 19-Feb-2018 | ShareCast |
Beximco buys stake in Bangladesh-based Nuvista f... | 19-Jan-2018 | ShareCast |
Beximco begins exporting Betapace generic to the... | 07-Nov-2017 | ShareCast |
Beximco begins export of Olopatadine to Canada | 18-Sep-2017 | ShareCast |
Beximco profits rise as it begins US exports | 27-Jan-2017 | ShareCast |
Beximco Pharma partners with BioCare in Malaysia | 25-Jan-2017 | ShareCast |
Beximco sales grow in first half | 20-Oct-2016 | ShareCast |
Currency | UK Pounds |
Price | 35.60p |
Change Today | -0.40p |
% Change | -1.11 % |
52 Week High | 73.00p |
52 Week Low | 35.02p |
Volume | 78 |
Shares Issued | 100.04m |
Market Cap | £35.61m |
RiskGrade | 190 |
Latest | Previous | |
---|---|---|
Final | Final | |
Ex-Div | 14-Nov-17 | n/a |
Paid | 18-Jan-18 | n/a |
Amount | 1.25 | 0.50 |
Time | Volume / Share Price |
08:00 | 78 @ 35.02p |
Chair | Ahmed Sohail Fasiur Rahman |
You are here: research